AMACR

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA019527

Antibody HPA020912

Antibody CAB001809

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant carcinoids, prostate, colorectal and liver cancers as well as several cases of malignant melanomas, thyroid, gastric and renal cancers exhibited moderate to strong positivity. Remaining malignancies showed distinct staining in fractions of cases but were in general negative.Colorectal, prostate and liver cancers displayed strong cytoplasmic immunoreactivity in several cases.Moderate to strong cytoplasmic immunoreactivity was observed in most prostate cancers and colorectal cancers and in rare cases of lung-, thyroid- and renal cancer. Remaining tumors were in general negative.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected